Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Intercept Pharmaceuticals (ICPT) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 32 quarters since 2013. Compare with ICPT stock chart to see long term trends.

ICPT stock compared to

ICPT Income Statement

Revenue, Net:83268000
Revenue Per Share:2.53
Cost of Goods & Services Sold:767000
Selling, General & Admin Expense:69956000
Research & Development Expense:51898000
Total Operating Expenses:123870000
Operating Income:-84242000
Net Income:-52147000
Earnings Per Share, Basic:-1.55
Shares Outstanding, Basic Avg:32970000

ICPT Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:1825000
Net Cash from Operations:-15975000
Net Cash from Financing Activities:-156000
Property, Plant & Equipment Purchases:1901000
Net Cash from Investing Activities:29844000
Net Change in Cash & Equivalents:14163000

ICPT Balance Sheet

Cash and Cash Equivalents:65654000
Accounts Receivable, Net:41549000
Inventories:9027000
Total Current Assets:545741000
Property, Plant & Equipment, Net:6326000
Total Assets:580489000
Accounts Payable:24594000
Total Short-Term Liabilities:179076000
Long Term Debt, Non-Current Portion:560582000
Total Liabilities:747342000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
FMR LLC
3,727,918 sh
-1,093,387 sh
-23%
$154,559
-$76,430
Vanguard Group Inc
2,739,825 sh
254,608 sh
10%
$113,593
-$5,474
Blackrock Inc.
2,179,635 sh
-205,411 sh
-9%
$90,369
-$23,898
Boxer Capital, LLC
1,176,000 sh
1,050,000 sh
833%
$48,757
$42,720
Ameriprise Financial Inc
861,278 sh
694,080 sh
415%
$35,709
$27,699
Goldman Sachs Group Inc
648,303 sh
229,482 sh
55%
$26,879
$6,814
Jacobs Levy Equity Management, Inc
347,246 sh
297,789 sh
602%
$14,397
$12,028
Northern Trust Corp
307,426 sh
-34,341 sh
-10%
$12,744
-$3,630
Renaissance Technologies LLC
244,700 sh
-75,500 sh
-24%
$10,145
-$5,196
Charles Schwab Investment Management Inc
201,070 sh
-2,833 sh
-1%
$8,337
-$1,432
Bank Of America Corp /De/
193,748 sh
-30,077 sh
-13%
$8,033
-$2,690
UBS Asset Management Americas Inc
160,516 sh
-5,750 sh
-3%
$6,654,993
-$1,310,812
Credit Suisse Ag/
137,965 sh
9,816 sh
8%
$5,719
-$421
D. E. Shaw & Co., Inc.
Call options for 113,700 sh
113,700 sh
NEW
$4,714
$4,714
Greenlight Capital Inc
100,000 sh
100,000 sh
NEW
$4,146
$4,146
Royal Bank Of Canada
78,538 sh
-31,029 sh
-28%
$3,256
-$1,994
Sei Investments Co
67,609 sh
-8,498 sh
-11%
$2,769
-$842
D. E. Shaw & Co., Inc.
61,287 sh
41,287 sh
206%
$2,541
$1,583
Morgan Stanley
57,432 sh
1,563 sh
3%
$2,381
-$295
Paloma Partners Management Co
46,055 sh
46,055 sh
NEW
$1,909
$1,909

Data imported from Intercept Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.